UvA-DARE (Digital Academic Repository)
123I-mIBG assessed cardiac sympathetic activity: standardizing towards clinical
implementation
Verschure, D.O.
Publication date
2017
Document Version
Other version
License
Other
Link to publication
Citation for published version (APA):
Verschure, D. O. (2017). 123I-mIBG assessed cardiac sympathetic activity: standardizing
towards clinical implementation.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)
and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open
content license (like Creative Commons).
12 3 I-m IB G a sse sse d c ardia c s ym pat he tic a cti vi ty: s ta nd ardi zin g t ow ard s c lin ica l im ple m en tat io n D erk O tto V ers ch ure
123
I-mIBG assessed
cardiac sympathetic activity:
standardizing towards
clinical implementation
Derk Otto Verschure
Uitnodiging
Voor het bijwonen van de openbare verdediging
van het proefschrift 123
I-mIBG assessed
cardiac sympathetic activity:
standardizing towards
clinical implementation
door Derk Otto Verschure
28 maart 2017 om 14:00 uur Aansluitend receptie Amsterdamse Academische Club
Oudezijds Achterburgwal 235 Amsterdam Derk Verschure Koninginneweg 48-2 1075EA Amsterdam d.o.verschure@amc.uva.nl 06-24631101 Paranimfen
Diederik van Wijk dfvanwijk@gmail.com
Michiel Peters mhvpeters@hotmail.com
Derk Otto Verschure
123
I-mIBG assessed cardiac sympathetic activity:
Processed on: 20-2-2017 Processed on: 20-2-2017 Processed on: 20-2-2017 Processed on: 20-2-2017 508097-L-bw-Verschure 508097-L-bw-Verschure 508097-L-bw-Verschure 508097-L-bw-Verschure
123I-mIBG assessed cardiac sympathetic activity:
standardizing towards clinical implementation
PhD thesis, University of Amsterdam, the Netherlands ISBN: 978-94-028-0501-7
Online: http://dare.uva.nl
© 2017 Derk Otto Verschure, Amsterdam, The Netherlands
All rights reserved. No part of this publication may be reproduced, stored of transmitted in any forms of by any means without written permission of the author.
Cover illustration: Steffie Padmos. www.steffiepadmos.com Lay-out: Lyanne Tonk. www.persoonlijkproefschrift.nl Printing: Ipskamp Printing BV, Enschede, the Netherlands
An ancillary research grant from GE Healthcare is gratefully acknowledged.
Financial support for publication of the thesis was kindly provided by: HERMES Medical Solutions, Sanofi, Boehringer Ingelheim.
123
I-mIBG assessed cardiac sympathetic activity:
standardizing towards clinical implementation
ACADEMISCH PROEFSCHRIFT
ter verkrijging van de graad van doctor
aan de Universiteit van Amsterdam
op gezag van de Rector Magnificus
prof. dr. ir. K.I.J. Maex
ten overstaan van een door het College voor
Promoties ingestelde commissie,
in het openbaar te verdedigen in de Agnietenkapel
op dinsdag 28 maart 2017, te 14:00 uur
door
Derk Otto Verschure
geboren te Schiedam
Processed on: 20-2-2017 Processed on: 20-2-2017 Processed on: 20-2-2017 Processed on: 20-2-2017 508097-L-bw-Verschure 508097-L-bw-Verschure 508097-L-bw-Verschure 508097-L-bw-Verschure
PROMOTIECOMMISSIE
Promotor: Prof. dr. B.L.F. van Eck-Smit Universiteit van Amsterdam
Copromotores: Dr. H.J. Verberne Universiteit van Amsterdam
Dr. G.A. Somsen Cardiologie Centra Nederland
Overige leden: Prof. dr. K. Nakajima Kanazawa University Prof. dr. J. Booij Universiteit van Amsterdam Prof. dr. J.J. Piek Universiteit van Amsterdam Dr. J.R. de Groot Academisch Medisch Centrum Prof. dr. J.F. Verzijlbergen Radboud Universiteit Nijmegen Dr. A.J.H.A. Scholte Universiteit Leiden
Faculteit: Geneeskunde
Financial support by the Dutch Heart Foundation for the publication of this thesis is gratefully acknowledged.
Ter herinnering aan mama
Voor Saar, Olivier en Stijn
Processed on: 20-2-2017 Processed on: 20-2-2017 Processed on: 20-2-2017 Processed on: 20-2-2017 508097-L-bw-Verschure 508097-L-bw-Verschure 508097-L-bw-Verschure 508097-L-bw-Verschure
LIST OF ABBREVIATIONS
123I-mIBG 123I-meta-iodobenzylguanidine 22q11.2 DS 22q11.2 deletion syndromeACE-I angiotensin converting enzyme inhibitor AMPT alpha-methyl-para-tyrosine
AR adrenergic receptor
ARB angiotensin II receptor blocker CCB calcium channel blocker CHD congenital heart disease CHF chronic heart failure
COMT catechol-O-methyl-transferase
DA dopamine
CRP C-reactive protein
e-CC estimated creatinine clearance e-GFR estimated glomerular filtration rate
HF heart failure
HR hazard ratio
H/M ratio heart-to-mediastinum ratio LVEF left ventricle ejection fraction MDRD modification of diet in renal disease
NE norepinephrine
NET norepinephrine transporter
NT-proBNP N-terminal pro B-type Natriuretic Peptide p.i. post injection
ROI region of interest
SPECT single photon emission computed tomography TCM tako-tsubo cardiomyopathy
Processed on: 20-2-2017 Processed on: 20-2-2017 Processed on: 20-2-2017 Processed on: 20-2-2017 508097-L-bw-Verschure 508097-L-bw-Verschure 508097-L-bw-Verschure 508097-L-bw-Verschure
TABLE OF CONTENTS
Introduction and outline: the role of 123I-mIBG in the assessment of cardiac sympathetic activity in patients with chronic heart failure
Netherlands Heart Journal. 2016;24:701-708.
Standardization and validation of cardiac 123I-mIBG
scintigraphy
¹²³I-mIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity
Nuclear Medicine Communication. 2015;36:279-85.
A European myocardial 123I-mIBG cross-calibration phantom study
Journal Nuclear Cardiology. 2017. E-publication ahead of print.
Impact of a predefined mediastinal ROI on inter-observer variability of planar 123I-mIBG heart-to-mediastinum ratio
Journal Nuclear Cardiology. 2014;21:605-13.
Polymorphism of SLC6A2 gene does not influence outcome of myocardial 123I-mIBG scintigraphy in patients with chronic heart failure
Journal Nuclear Cardiology. 2016. E-publication ahead of print.
Vascular time-activity variation in patients undergoing 123I-mIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake
European Journal Nuclear Medicine and Molecular Imaging. 2011;38:1132-8.
Renal function in relation to cardiac 123I-mIBG scintigraphy in patients with chronic heart failure
International Journal of Molecular Imaging. 2012:434790.
Chapter 1 PART I Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 11 27 43 57 75 89 105
125 145 163 185 199 229 227 237 PART II Chapter 8 Chapter 9 Chapter 10 Part III Chapter 11 Chapter 12 Chapter 13 Chapter 14 Appendix
Prognostic value of cardiac 123I-mIBG scintigraphy
For what endpoint does myocardial 123I-mIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis
European Heart Journal Cardiovascular Imaging. 2014;15:996-1003.
Myocardial 123I-mIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure
Journal Nuclear Cardiology. 2016. E-publication ahead of print.
Does cardiac 123I-mIBG scintigraphy predict appropriate ICD therapy in stable chronic Heart failure patients?
Submitted for publication.
Cardiac 123I-mIBG scintigraphy in patients other than
heart failure
Cardiac sympathetic activity in 22q11.2 deletion syndrome
International Journal Cardiology. 2016;212:346-51.
Tako-tsubo cardiomyopathy: how to understand possible pathophysiological mechanism and the role of 123I-mIBG imaging
Journal Nuclear Cardiology. 2014;21:730-8.
Summary, general discussion, future perspective and conclusions
Samenvatting, algemene discussie, perspectief en conclusies
Dankwoord Curriculum Vitae Bibliography